scholarly article | Q13442814 |
P50 | author | Jeffrey I. Weitz | Q29561411 |
P2093 | author name string | Cynthia Wu | |
Clive Kearon | |||
David Ginsburg | |||
Dhruva J Dwivedi | |||
Laura Pepler | |||
Patricia C Liaw | |||
Jim Julian | |||
Zakhar Lysov | |||
Karl Desch | |||
John Waye | |||
P2860 | cites work | Identification, cloning, and regulation of a novel endothelial cell protein C/activated protein C receptor | Q24323189 |
The crystal structure of the endothelial protein C receptor and a bound phospholipid | Q27639046 | ||
Identification of the protein C/activated protein C binding sites on the endothelial cell protein C receptor. Implications for a novel mode of ligand recognition by a major histocompatibility complex class 1-type receptor | Q28139028 | ||
A 23bp insertion in the endothelial protein C receptor (EPCR) gene impairs EPCR function | Q28202832 | ||
Prevalence of a 23bp insertion in exon 3 of the endothelial cell protein C receptor gene in venous thrombophilia | Q28214512 | ||
Endothelial cell protein C receptor plays an important role in protein C activation in vivo | Q28628837 | ||
Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion | Q29616531 | ||
Common vs. rare allele hypotheses for complex diseases | Q34038820 | ||
Disruption of the endothelial cell protein C receptor gene in mice causes placental thrombosis and early embryonic lethality. | Q34148383 | ||
Protein C activators from snake venoms and their diagnostic use. | Q34574878 | ||
A genome-wide association study of venous thromboembolism identifies risk variants in chromosomes 1q24.2 and 9q. | Q36166323 | ||
Shifting paradigm of association studies: value of rare single-nucleotide polymorphisms | Q36477625 | ||
Prophylaxis and treatment of venous thromboembolism in individuals with inherited thrombophilia. | Q36685162 | ||
The endothelial cell protein C receptor augments protein C activation by the thrombin-thrombomodulin complex. | Q37331775 | ||
A genome-wide association study for venous thromboembolism: the extended cohorts for heart and aging research in genomic epidemiology (CHARGE) consortium | Q37708719 | ||
Beta protein C is not glycosylated at asparagine 329. The rate of translation may influence the frequency of usage at asparagine-X-cysteine sites | Q38340035 | ||
Protein-C: biochemistry, physiology, and clinical implications | Q40138549 | ||
Regulated endothelial protein C receptor shedding is mediated by tumor necrosis factor-alpha converting enzyme/ADAM17. | Q40199261 | ||
The Ser219-->Gly dimorphism of the endothelial protein C receptor contributes to the higher soluble protein levels observed in individuals with the A3 haplotype | Q40330593 | ||
Selective modulation of protein C affinity for EPCR and phospholipids by Gla domain mutation. | Q40474485 | ||
Activation mechanism of anticoagulant protein C in large blood vessels involving the endothelial cell protein C receptor | Q41043951 | ||
Glycosylation of human protein C affects its secretion, processing, functional activities, and activation by thrombin | Q41683621 | ||
Plasma levels of endothelial protein C receptor respond to anticoagulant treatment. | Q43847726 | ||
Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism | Q44548746 | ||
Influence of thrombophilia on risk of recurrent venous thromboembolism while on warfarin: results from a randomized trial | Q46368145 | ||
Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO loci to VTE risk: results from a GWAS approach. | Q51773327 | ||
Mutations which introduce free cysteine residues in the Gla-domain of vitamin K dependent proteins result in the formation of complexes with alpha 1-microglobulin. | Q52520223 | ||
Fast functional protein C assay using Protac, a novel protein C activator. | Q54017734 | ||
The Protein C Pathway | Q56502503 | ||
A simple, automated functional assay for protein C | Q69672746 | ||
Compound heterozygous protein C deficiency resulting in the presence of only the beta-form of protein C in plasma | Q71571067 | ||
Bimodal distribution of soluble endothelial protein C receptor levels in healthy populations | Q73690764 | ||
The endothelial cell protein C receptor | Q73818060 | ||
Prevalence of the 23bp endothelial protein C receptor (EPCR) gene insertion in the Irish population | Q74091017 | ||
The endothelial protein C receptor (EPCR) 23 bp insert mutation and the risk of venous thrombosis | Q74553517 | ||
Endothelial cell protein C receptor (EPCR) gene exon III, 23 bp insertion mutation in the Turkish pediatric thrombotic patients | Q78800642 | ||
Inherited thrombophilia and venous thromboembolism | Q79197431 | ||
A haplotype of the EPCR gene is associated with increased plasma levels of sEPCR and is a candidate risk factor for thrombosis | Q79202743 | ||
P433 | issue | 11 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | endothelium | Q111140 |
venous thromboembolism | Q9397786 | ||
P304 | page(s) | 2674-2681 | |
P577 | publication date | 2013-09-19 | |
P1433 | published in | Arteriosclerosis, Thrombosis, and Vascular Biology | Q4797542 |
P1476 | title | Targeted gene sequencing identifies variants in the protein C and endothelial protein C receptor genes in patients with unprovoked venous thromboembolism | |
P478 | volume | 33 |
Q88933117 | Coagulation factor V gene 1691G>A polymorphism as an indicator for risk and prognosis of lower extremity deep venous thrombosis in Chinese Han population |
Q40239904 | Endothelial protein C receptor polymorphisms and risk of sepsis in a Chinese population |
Q40383043 | Identification of Genetic Variants Linking Protein C and Lipoprotein Metabolism: The ARIC Study (Atherosclerosis Risk in Communities). |
Q35070627 | Multilocus genetic risk scores for venous thromboembolism risk assessment |
Q47983961 | Thrombophilic Gene Mutations in Relation to Different Manifestations of Venous Thromboembolism: A Single Tertiary Center Study. |
Search more.